A 17-gene stemness score for rapid determination of risk in acute leukaemiaStanley Ng, Jean Wang, Bob Löwenberg et al.|Nature|2016Cited by 916
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBarbara Eichhorst, Christian Buske, Tadeusz Robak et al.|Annals of Oncology|2015Cited by 604
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBarbara Eichhorst, Ulrich Mey, Tadeusz Robak et al.|Annals of Oncology|2020Cited by 568
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemiaKlaus H. Metzeler, Christian Buske|Blood|2008Cited by 445
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcomeChristian Buske, Eva Hoster, Martin Dreyling et al.|Blood|2006Cited by 217